Lantus The insulin cap previously was included in the Democrats’ “Build Back Better” legislation but rescued to become a standalone bill.

The U.S. House of Representatives has passed legislation that would cap the out-of-pocket cost of insulin at $35 per month, lowering drug costs for more than seven million diabetes patients. Introduced by three Democrats, the Affordable Insulin Now Act passed mostly along party lines.

“No American should have to choose between paying for life-saving insulin and other basic necessities like food and rent,” Rep. Angie Craig of Minnesota, one of the bill’s co-sponsors, said in a statement. “And yet, today, all across the country, patients are risking their own lives by rationing doses or skipping treatments entirely due to the skyrocketing cost of their medications.”

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.